{
  "catalogId": "fb7bc738-93c8-4543-9c23-f6d80e4cd9fe",
  "name": "KALYDECO 150 MG FILM COATED TABLETS",
  "status": "draft",
  "category": "prescription",
  "registrationValidity": "valid",
  "registrationNumber": "153 89 34269 00",
  "treatmentDescriptions": "Kalydeco tablets are indicated for the treatment of patients with cystic fibrosis (CF) aged 6 years and older and weighing 25 kg or more who have one mutation in the CFTR gene that is responsive to ivacaftor potentiation based on clinical and/or in vitro assay data. Limitations of use : Kalydeco is not effective in patients with CF who are homozygous for the F508del mutation in the CFTR gene.",
  "termsOfIssue": "Prescription required",
  "form": "film coated tablets",
  "route": "per os",
  "site": "",
  "method": "",
  "administrationNotes": "",
  "ingredients": "IVACAFTOR",
  "codes": {
    "atc5": {
      "system": "WHO ATC Classification",
      "code": "R07AX02",
      "name": "IVACAFTOR"
    }
  },
  "contraindications": "",
  "sideEffect": "",
  "warnings": "תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת",
  "alternativeMedications": [],
  "packaging": [
    {
      "name": "KALYDECO 150MG 56TAB",
      "manufacturer": {
        "name": "מדיסון",
        "countryOfOrigin": "IL"
      },
      "strength": {
        "value": 0,
        "unit": ""
      },
      "quantity": {
        "value": 56.0,
        "unit": "units"
      },
      "packagingDescription": "BLISTER PVC/ALUMINIUM",
      "shelfLife": "48",
      "storageConditions": "",
      "codes": {
        "moh": "7599",
        "yarpa": "56073",
        "pharmasoft": "11256"
      },
      "manufacturersAdministrationRecommendation": "",
      "pricing": {
        "currency": "ILS",
        "maxWholesalePrice": 40509.1043,
        "retailMargin": 10.0,
        "maxRetailPrice": 44560.01473,
        "maxPriceWithVAT": 52580.81505
      }
    }
  ],
  "metadata": {
    "version": "1.4",
    "lastUpdated": "2025-08-01T12:18:44.426427"
  }
}